复发缓解型多发性硬化灰质钠蓄积与萎缩对应神经递质图谱
研究纳入55例复发缓解型多发性硬化患者与55名健康对照,用23Na-MRI和1H-MRI比较灰质总钠浓度与体积差异,发现患者双侧额颞枕叶及海马等区钠浓度升高,且灰质损伤空间分布与5-羟色胺、多巴胺、GABA能、阿片及去甲肾上腺素能神经递质图谱相关。
要点
- 23Na-MRI可显示复发缓解型多发性硬化患者皮质区域广泛灰质钠蓄积,并与扩展残疾状态量表评分正相关。
- 灰质钠蓄积或萎缩的空间分布与5-羟色胺、多巴胺、GABA能、阿片及去甲肾上腺素能神经递质图谱相关。
- 左侧海马、壳核和苍白球体积与病程负相关。
核心结论
- 复发缓解型多发性硬化患者钠蓄积主要见于皮质区域并与躯体残疾相关,特定神经递质系统的区域灰质损伤可能解释部分临床表现。
研究设计与样本
- 研究纳入55例复发缓解型多发性硬化患者和55名健康对照,采用23Na-MRI和1H-MRI,通过基于体素和基于感兴趣区分析比较两组灰质总钠浓度与体积差异,并用JuSpace工具箱分析灰质损伤模式与基于图谱的神经递质分布的空间相关性。
关键影像表现/征象
- 与健康对照相比,复发缓解型多发性硬化患者双侧额叶、颞叶、枕叶皮质、梭状回以及右侧海马和海马旁回总钠浓度显著升高。
- 双侧颞下回、右侧枕上回和梭状回的总钠浓度与扩展残疾状态量表评分呈显著正相关(r=0.371-0.383,p≤0.01)。
- 左侧海马、壳核和苍白球体积与病程呈显著负相关(r=-0.351至-0.412,p≤0.01)。
- 复发缓解型多发性硬化患者的灰质钠蓄积或萎缩与5-羟色胺、多巴胺、GABA能、阿片及去甲肾上腺素能神经递质的空间分布相关,且上述对齐程度与临床特征相关。
临床应用与阅片要点
- 23Na-MRI可揭示多发性硬化患者灰质潜在的代谢改变,反映疾病早期的神经轴索损伤。
- 与特定神经递质分布对应的灰质损伤可能有助于揭示部分临床表现并进一步指导临床治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To explore gray matter (GM) sodium accumulation and volume reduction in relapsing-remitting multiple sclerosis (RRMS) patients by sodium magnetic resonance imaging (23Na-MRI) and proton MRI (1H-MRI), respectively, and to investigate the relationship between regional GM damage, atlas-based neurotransmitter distribution, and clinical characteristics.
MATERIALS AND METHODS: Fifty-five RRMS patients and 55 healthy controls (HC) were included in this study. We compared the differences in GM total sodium concentration (TSC) and volume between the two groups by voxel-based and region of interest-based analyses, respectively, and then explored the relationship between regional GM damage and clinical characteristics. Spatial correlations between GM damage patterns and atlas-based neurotransmitter maps were investigated using the JuSpace toolbox.
RESULTS: Compared with HC, RRMS patients showed significant TSC increases in bilateral frontal, temporal, occipital cortices, fusiform gyrus, as well as in the right hippocampus and parahippocampal gyrus. The TSC of bilateral inferior temporal gyrus, right superior occipital gyrus and fusiform gyrus was significantly positively correlated with expanded disability status scale (r = 0.371-0.383, p ≤ 0.01), whereas the volumes of left hippocampus, putamen and pallidum were significantly negatively correlated with disease duration (r = -0.351 to -0.412, p ≤ 0.01). The GM sodium accumulation or atrophy in RRMS correlated with the spatial distribution of serotonin, dopamine, GABAergic, opioid, and noradrenaline neurotransmitters, and the degree of above alignment was related to clinical characteristics.
CONCLUSION: Sodium accumulation occurs primarily in cortical regions of RRMS patients and is associated with physical disability. Regional GM damage with specific neurotransmitter systems may explain some clinical manifestations.
KEY POINTS: Question 23Na-MRI can detect early metabolic damage, but the relationship between brain metabolic damage and the vulnerability of specific neurotransmitter systems in multiple sclerosis patients remains unclear. Findings Alterations in GM sodium concentration were widespread across cortical regions, and the GM damage pattern was spatially correlated with neurotransmitter distribution. Clinical relevance 23Na-MRI could reveal potential metabolic alterations in the GM of multiple sclerosis patients, reflecting neural axonal damage early in the disease. GM damage corresponding to specific neurotransmitter distribution may help to reveal some clinical manifestations and further guide clinical treatment.
引用
- Xie Y, Wu S, Zhu H, et al. Gray matter sodium accumulation and atrophy in relapsing-remitting multiple sclerosis correspond to neurotransmitter maps. Eur Radiol. 2025. PMID: 40739057. doi:10.1007/s00330-025-11892-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。